About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials | 4,236 Studies Recruiting

Clinical TrialsSchizophrenia

Schizophrenia Clinical Trials

Browse 4,236 clinical trials for schizophrenia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3341-3360 of 4,236 trials

RecruitingInvestigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis UseCognitive impairment is well established in people with psychosis and is associated with cannabis use.NCT05445180·Montreal, Quebec CompletedTo Evaluate the Impact of Treatment Interruption on Re-initiation of BifeprunoxThe purpose of this study is to investigate a safe treatment interruption interval(s) for re-initiation of bifeprunox at a therapeutic dose.NCT00141479·Wichita, Kansas CompletedRisk Factors for Postpartum PsychosisA range of psychological disorders occur in women in the postpartum period.NCT00872313·Nanjing, Jiangsu

Related Searches

Data from ClinicalTrials.govTerms

CompletedEfficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With HaloperidolFlunarizine is a calcium channel blocker traditionally used for the treatment of vertigo and migraine.NCT00740259·São Paulo, São Paulo

CompletedUsing D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for SchizophreniaThis study will examine whether pretreatment with D-cycloserine before cognitive behavioral therapy can reduce impairments still present in people with stable cases of…NCT00742079·Boston, Massachusetts

Enrolling by invitationCombining HD-tDCS and iTBS in Treating Negative Symptoms of SchizophreniaDysfunction of the dorsolateral prefrontal cortex (DLPFC) is central to the persistence of negative symptoms in schizophrenia.NCT07680959·Taipei

CompletedMetformin for the Prevention of the Metabolic Side-effects of ZyprexaWe hypothesize that metformin co-administered with olanzapine will be well tolerated and associated with significantly less insulin resistance, weight gain and dyslipidemia as…NCT00682448·Chicago, Illinois

CompletedEvaluating the Use of Peer Specialists to Deliver Cognitive Behavioral Social Skills TrainingThe Veterans Health Administration (VHA) is advocating that Veterans with serious mental illness (SMI) receive recovery-oriented, rehabilitation approaches that target real-world…NCT03467243·Pittsburgh, Pennsylvania

CompletedReducing Stigma Among Healthcare Providers (RESHAPE-cRCT)A growing number of trials have demonstrated treatment effectiveness for mental illness by non-specialist providers, such as primary care providers, in low-resource settings.NCT04282915·Pokhara, Gandaki

CompletedClinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in SchizophreniaThis study is designed to compare the efficacy and drug tolerability of two strategies for the treatment of schizophrenia.NCT01164059·Aachen and 17 others

CompletedRecovery Group PilotThe purpose of this study is to develop and evaluate a low-cost, joint consumer/counselor-led, health education and support intervention that will foster self-care and recovery…NCT00522613·Portland, Oregon

RecruitingBrain Imaging of Cognition Inn Schizophrenia and DepressionSchizophrenia and depression are among the most disabling disorders in all of medicine.NCT04159662·Ottawa, Ontario

CompletedStudy Of Talnetant Versus Placebo And Risperidone In SchizophreniaThis study will evaluate whether talnetant (200mg, 400mg, 600mg) twice a day is effective compared to placebo and risperidone 1-3mg twice a day in treating the positive and…NCT00103727·Little Rock, Arkansas and 21 others

UnknownModulation of Repetitive Transcranial Magnetic Stimulation on Hippocampal Neurogenesis and Functional Network in Patients With SchizophreniaBased on the hypothesis that high-frequency repetitive transcranial magnetic stimulation(rTMS) on the right dorsolateral prefrontal cortex(DLPFC) and left parietal cortex(LPC)…NCT03608462·Shanghai, Shanghai Municipality

CompletedStudy of Immunotherapy in Autoantibody Positive PsychosisPsychosis is a mental health problem that causes people to perceive or interpret things differently from those around them, often involving hallucinations or delusions.NCT02449746·Birmingham and 4 others

UnknownMagnetoencephalographic (MEG) Correlates of Negative Symptoms in Patients Suffering From Schizophrenia and Their Influence by Add-on TreatmentsThe objective of the suggested study is to identify changes in MEG correlates caused by the add-on treatment with the changes in negative symptoms of schizophrenia by comparing…NCT00894296·Givat Shmuel

UnknownCharacterization of Emotional Processing of Information in Bipolar Disorder and Schizophrenic PatientsIn the case of psychotic disorders such as bipolar disorder or schizophrenia, attention dysfunction contribute, according to the theories of neuroscience, the development of mood…NCT02841345·La Tronche

TerminatedAripiprazole, Abilify Maintena Collaborative Clinical ProtocolAn Open-label, Multi-center, Longitudinal, Within-subject Comparison Study to Evaluate the Effects of Aripiprazole Once Monthly in Subjects with Schizophrenia on 30-, 90-, and…NCT02717130·Columbia, Missouri and 3 others

CompletedPEARL Schizophrenia MaintenanceLurasidone HCI is a compound that is FDA-approved for the treatment of schizophrenia.NCT01435928·Springdale, Arizona and 74 others

RecruitingMedical Phenotyping of NHS General Adult Psychiatry (GAP) InpatientsThis observational study will characterise the general psychiatric and general medical phenotypes of 100 adults, sequentially admitted to NHS General Adult Psychiatry (GAP)…NCT07398365·Livingston, West Lothian

PreviousPage 168 of 212Next